Simon Portsmouth

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. doi Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078
    Simon Portsmouth
    Pfizer Global Research and Development, New York, NY, USA
    Antiviral Res 97:60-5. 2013
  2. pmc The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa
    Quazi Ataher
    Pfizer Inc, New York, NY 10017, USA
    J Int AIDS Soc 15:2. 2012

Collaborators

Detail Information

Publications2

  1. doi Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078
    Simon Portsmouth
    Pfizer Global Research and Development, New York, NY, USA
    Antiviral Res 97:60-5. 2013
    ..For both concordant and discordant samples, population sequencing appropriately identified R5 samples with low levels of non-R5-using virus...
  2. pmc The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa
    Quazi Ataher
    Pfizer Inc, New York, NY 10017, USA
    J Int AIDS Soc 15:2. 2012
    ..This study was undertaken to evaluate HIV-1 co-receptor tropism in the developing world where non-B subtypes predominate, in order to assess the therapeutic and prophylactic potential of CCR5 antagonists in these regions...